Cerebrocare is one of the largest neuroscience managed services organizations in the world. It delivers neurological care to hospitals, inpatient facilities and communities through technological and clinical delivery platforms, spanning telehealth, medical imaging, ancillary diagnostic testing, infusion therapy services, and clinical trials and research.
Its services include inpatient telehealth rounding, outpatient telehealth delivery of neurological care, and customized Hospital Neuroscience Programs built around the needs of individual inpatient facilities and communities. The organization also develops brick-and-mortar outpatient neurology practices, manages outpatient neurology practices, and operates proprietary regional teleneurology clinics that provide specialty outpatient telehealth and ancillary services.
Beyond neurology, Cerebrocare provides subspecialty telehealth services in cardiology, rheumatology and psychiatry, alongside subspecialty ancillary testing in cardiology and neurology. It runs infusion centers and imaging centers of its own. Research and development covers healthcare software and technology development, regular healthcare publications and clinical trials.
The company employs more than 100 people, whom it calls partners, drawn from across the United States and abroad. It describes its work as mission-driven, with an emphasis on fostering high-quality healthcare services in the communities it serves.
